What is the dosage of amoxicillin-clavulanate (Augmentin) for tonsillitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin-Clavulanate Dosing for Tonsillitis

For adults with tonsillitis, use amoxicillin-clavulanate 875 mg/125 mg twice daily for 10 days, or 500 mg/125 mg three times daily for more severe infections or when antibiotic resistance is suspected. 1, 2

Adult Dosing Recommendations

Standard dosing for adults is 875 mg/125 mg twice daily or 500 mg/125 mg every 8 hours for respiratory tract infections including tonsillitis. 1 The FDA-approved dosing specifically indicates that for more severe infections and infections of the respiratory tract, the dose should be one 875 mg/125 mg tablet every 12 hours or one 500 mg/125 mg tablet every 8 hours. 1

High-Dose Regimen Indications

Consider the higher dose of 2000 mg/125 mg twice daily in adults when: 3, 4

  • Recent antibiotic use within the past 4-6 weeks
  • Previous antibiotic treatment failure
  • Close contact with healthcare environments or daycare centers
  • High community prevalence of penicillin-resistant Streptococcus pneumoniae (>10%)
  • Moderate to severe infection presentation
  • Comorbidities (diabetes, chronic heart/lung/liver/kidney disease)
  • Age >65 years or immunocompromised status

Pediatric Dosing Recommendations

For children ≥12 weeks with tonsillitis, use 45 mg/kg/day divided every 12 hours (or 40 mg/kg/day every 8 hours) for more severe infections. 3, 1 For less severe infections, 25 mg/kg/day every 12 hours (or 20 mg/kg/day every 8 hours) is appropriate. 3

High-Dose Pediatric Regimen

Use 80-90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in two divided doses (maximum 4000 mg/day) for children with risk factors: 3, 4, 5

  • Age <2 years
  • Daycare attendance
  • Recent antibiotic use within 30 days
  • Areas with high prevalence of resistant S. pneumoniae
  • Concurrent conjunctivitis (provides coverage for Moraxella catarrhalis)

The 14:1 ratio formulation in high-dose amoxicillin-clavulanate causes less diarrhea than standard formulations, making it better tolerated in children. 4

Treatment Duration

The recommended treatment duration for tonsillitis is 10 days. 1, 2 This duration has been studied specifically for acute tonsillitis and recurrent tonsillitis. 6, 2 Clinical studies demonstrate that 10-day courses achieve bacteriologic eradication rates of 97-99% for group A streptococcal pharyngotonsillitis. 7

Clinical Response Monitoring

Evaluate clinical response within 48-72 hours of initiating therapy. 3, 4 If no improvement occurs after 72 hours, consider changing antibiotics or reevaluating the diagnosis with cultures. 4 Research shows that clinical cure rates at day 12 range from 85-93% with amoxicillin-clavulanate for recurrent tonsillitis. 7

Administration Considerations

Administer amoxicillin-clavulanate at the start of meals to enhance absorption of clavulanate and minimize gastrointestinal intolerance. 1 While the medication may be taken without regard to meals, taking it with food significantly reduces nausea and diarrhea. 1

Critical Dosing Pitfalls to Avoid

  • Never substitute two 250 mg/125 mg tablets for one 500 mg/125 mg tablet - they contain the same amount of clavulanic acid (125 mg each), making the substitution inappropriate. 1
  • Do not use 250 mg/125 mg tablets in children weighing <40 kg due to incorrect amoxicillin-to-clavulanate ratios compared to pediatric formulations. 1
  • Avoid underdosing in areas with high penicillin-resistant S. pneumoniae prevalence - always use high-dose formulations in these settings. 3

Efficacy Data

Research demonstrates that amoxicillin-clavulanate achieves bacteriologic eradication in 94-99% of cases at 12 days and maintains these rates at 3-month follow-up for recurrent tonsillitis. 7 In pediatric suppurative tonsillitis, the overall response rate is 94.5% with rapid symptom relief. 8 Group A streptococci are eradicated in 86% of cases with 10-day treatment courses. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.